[Federal Register Volume 62, Number 145 (Tuesday, July 29, 1997)]
[Notices]
[Pages 40537-40538]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-19854]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Cancer Institute Special Emphasis Panel (SEP) meetings:

    Name of SEP: Pivotal Clinical Trials for Chemoprevention Agent 
Development.
    Date: August 18-19, 1997.
    Time: August 18--7:00 a.m.-5:00 p.m.; August 19--8:00 a.m.-5:00 
p.m.
    Place: Double Tree Hotel, 1750 Rockville Pike, Rockville, Md 
20852.
    Contact Person: Ray Bramhall, PhD., Scientific Review 
Administrator, National Cancer Institute, NIH, Executive Plaza 
North, Room 636, 6130 Executive Boulevard, MSC 7410, Bethesda, Md 
20892-7410, Telephone: 301/496-3428.
    Purpose/Agenda: To evaluate and review grant applications.

    Name of SEP: Chemoprevention in Genetically-Identified High-Risk 
Groups: Interactive Research and Development Project.
    Date: August 25-26, 1997.
    Time: August 25--8:30 a.m.-5:00 p.m.; August 26--8:00 a.m.-5:00 
p.m.
    Place: Hyatt Regency Bethesda, 1 Bethesda Metro Center, 
Bethesda, Md 20814.
    Contact Person: Ray Bramhall, PhD., Scientific Review 
Administrator, National Cancer Institute, NIH, Executive Plaza 
North, Room 636, 6130 Executive Boulevard, MSC 7410, Bethesda, Md 
20892-7410, Telephone: 301/496-3428.
    Purpose/Agenda: To evaluate and review grant applications.
    These meetings will be closed in accordance with the provisions 
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and the discussions could reveal confidential trade 
secrets or commerical property such as patentable material and 
personal information concerning individuals associated with the 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    (Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395,

[[Page 40538]]

Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, 
Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, 
Cancer Control)

    Dated: July 22, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-19854 Filed 7-28-97; 8:45 am]
BILLING CODE 4140-01-M